The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy

Leukemia Research

Volumn 39, Issue 3, 2015, Pages 318-322

  Rybka, Justyna ^a   Butrym, Aleksandra ^a   Wróbel, Tomasz ^a   Jaźwiec, Bozena ^a   Stefanko, Ewa ^a   Dobrzyńska, Olga ^a   Poreba, Rafał ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute myeloid leukemia; Complete remission; Induction therapy; Toll like receptors

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CD34 ANTIGEN; CYTARABINE; LACTATE DEHYDROGENASE; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; ANTINEOPLASTIC AGENT; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; HUMAN; LEUKEMIA REMISSION; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOMONOCYTIC LEUKEMIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; VERY ELDERLY; ADOLESCENT; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETICS; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84923854434     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2015.01.002     Document Type: Article

References (20)

1. Uematsu S., Akira S. Toll-like receptors and innate immunity. J Mol Med 2006, 84:712-725.
2. Schmausser B., Andrulis M., Endrich S., Muller-Hermelink H.K., Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005, 295:179-185.
3. Merrell M.A., Ilvesaro J.M., Lehtonen N., et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 2006, 4:437-447.
4. Droemann D., Albrecht D., Gerdes J., et al. Human lung cancer cell express functionally active Toll-like receptor 9. Respir Res 2005, 6:1.
5. He W., Liu Q., Wang L., Chen W., Li N., Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 2007, 44:2850-2859.
6. Bahnhorst J., Rasmussen T., Moen S.H., et al. Toll like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia 2006, 20(6):138-1144.
7. Jego G., Batailie R., Geffroy-Luseau A., Descamps G., Pellat-Deceunynck C. Pathogen-associated molecular patterns are growth and survival factors for human meloma cells through Toll-like receptors. Leukemia 2006, 20:1130-1137.
8. Spaner D.E., Shi Y., White D., et al. Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia 2006, 20:286-295.
9. Li X., Jiang S., Tapping R.I. Toll-like receptor signaling in cell proliferation and survival. Cytokine 2010, 49:1-9.
10. Hasan U.A., Trinchieri G., Vlach J. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J Biol Chem 2005, 280:20620-20627.
11. Huang B., Zhao J., Unkeless J.C., Feng Z.H., Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008, 27:218-224.
12. Swann J.B., Vesely M.D., Silva A., et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorgenesis. Proc Natl Acad Sci U S A 2008, 105:652-656.
13. Purdue M.P., Lan Q., Wang S.S., et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2009, 30:275-281.
14. Lazarus R., Raby B.A., Lange C., et al. Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004, 170:594-600.
15. Kesh S., Mensah N.Y., Peterlongo P., et al. TLR1 and TLR6 polymorphism are associated with susceptibility to invasive aspregillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci 2005, 1062:95-103.
16. Nieters A., Beckmann L., Deeg E., Becker N. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006, 7:615-624.
17. Torok A.M., Bouton A.H., Goldberg J.B. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll like receptor 5-dependent and -independent pathways. Infect Immun 2005, 73:1523-1531.
18. Chiron D., Bekeredijan-ding I., Pellat-deceunynck C., et al. Toll-like receptors: lessons to learn from normal and malignant human B-cells. Blood 2008, 12:2205-2213.
19. Corthals S.L., Wynne K., She K., et al. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukemia. Br J Haematol 2006, 105:3641-3647.
20. Reid G.S.D., She K., Terrett L., Food M.R., Trudeau J.D., Schultz K.R. CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward Th1 response. Blood 2005, 105:3641-3647.